Abstract
The prevalence of allergic disease has dramatically increased over the past 30 years in Westernized countries. It is unlikely that the rapid increase in the prevalence of allergic disease is the result of genetic changes, which highlights the importance of environmental factors in the development of allergic disease. The “hygiene hypothesis” was put forward in 1989 and focused attention on the notion that exposure to microbes and their products in early life can modify the risk for development of allergic disease. Infections were thought to polarize the immunological response toward a Th2-mediated immune response causing allergic disease. However, it is likely that the Th1/Th2 imbalance is too simplistic to explain the increased prevalence of allergic disease. Current research is focusing on understanding the role of T-regulatory cells in inducing a state of tolerance and the resulting modified Th2 response observed in natural and induced tolerance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Kay AB (2001) Allergy and allergic diseases. N Engl J Med 344:30–37
Johansson SGO, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T et al (2001) A revised nomenclature for allergy. Allergy 56:813–824
Holt PG, Thomas WR (2005) Sensitization to airborne environmental allergens: unresolved issues. Nat Immunol 6:957–960
The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee (1998) Worldwide variation in prevalence of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 351:1225–1232
Aberg N, Hesselmar B, Aberg B, Eriksson B (1995) Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991. Clin Exp Allergy 25:815–819
Celedon JC, Soto-Quiros ME, Hanson LA, Weiss ST (2002) The relationship among markers of allergy, asthma, allergic rhinitis, and eczema in Costa Rica. Pediatr Allergy Immunol 13:91–97
Ninan TK, Russell G (1992) Respiratory symptoms and atopy in Aberdeen school-children: evidence from two surveys 25 years apart. BMJ 304:873–875
von Mutius E, Martinez FD, Fritzch C, Nicolai T, Roell G, Thiemann HH (1994) Prevalence of asthma and atopy in two areas of east and West Germany. Am J Respir Crit Care Med 149:358–364
von Mutius E, Weiland SK, Fritasch C, Duhme H, Keil U (1998) Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. Lancet 351:862–866
Upham JW, Holt PG (2005) Environment and development of atopy. Curr Opin Allergy Clin Immunol 5:67–172
Strachan DP (1989) Hay fever, hygiene and household size. BMJ 299:1259–1260
Mosmann TR, Coffman RL (1989) Th1 and Th2 cells: differential patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145–173
Romagnani S (1994) Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:27–257
Cooke A, Zaccone P, Raine T, Phillips JM, Dunne DW (2004) Infection and autoimmunity: are we winning the war, only to lose the peace? Trends Parasitol 20:316–321
Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911–920
Strachan DP (1997) Allergy and family size, a riddle worth solving. Clin Exp Allergy 27:235–236
Karmaus W, Botezan C (2002) Does a higher number of siblings protect against the development of allergy and asthma? A review. J Epidemiol Community Health 56:209–217
Cullinan P (2006) Childhood allergies, birth order and family size. Thorax 61:3–5
Sacks G, Sargent I, Redman C (1999) An innate view of human pregnancy. Immunol Today 20:114–118
Karmaus W, Arshad SH, Sadeghnejad A, Twiselton R (2004) Does maternal immunoglobulin E decrease with increasing order of live offspring? Investigation into maternal immune tolerance. Clin Exp Allergy 34:853–859
Westergaard T, Begtrup K, Rostgaard K, Krause TG, Benn CS, Melbye M (2003) Reproductive history and allergic rhinitis among 31145 Danish women. Clin Exp Allergy 33:301–305
Forastiere F, Sunyer J, Farchi S, Corbo G, Pistelli R, Baldacci S et al (2005) Number of offspring and maternal allergy. Allergy 60:510–514
Devereux G, Barker RN, Seaton A (2002) Antenatal determinants of neonatal immune responses to allergens. Clin Exp Allergy 32:43–50
Sunyer J, Anto JM, Harris J, Torrent M, Vall O, Cullinan P et al (2001) Maternal atopy and parity. Clin Exp Allergy 31:1352–1355
Karmaus W, Eneli I (2003) Maternal atopy and the number of offspring, is there an association? Pediatr Allergy Immunol 14:470–474
Harris JM, White C, Moffat S, Mills P, Newman Taylor AJ, Cullinan P (2004) New pregnancies and loss of allergy. Clin Exp Allergy 34:369–372
Aluvihare VR, Kallikourdis M, Betz AG (2004) Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 5:266–271
Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD25+CD4+ regulatory T-cell subset. Immunology 112:38–43
Prescott SL, Taylor A, Roper J, Wahdan A, Noakes P et al (2005) Maternal reactivity to fetal alloantigens is related to newborn immune responses and subsequent allergic disease. Clin Exp Allergy 35:417–425
Thomas W, Hales B, Smith W (2005) Genetically engineered vaccines. Curr Allergy Asthma Rep 5:388–393
Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R (2001) Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen, a population-based cross-sectional study. Lancet 357:752–756
Cullinan P, MacNeill SJ, Harris J, Moffat S, White C, Mills P et al (2004) Early allergen exposure, skin prick responses, and atopic wheeze at age 5 in English children, a cohort study. Thorax 59:855–861
Woodcock A, Lowe LA, Murray CS, Simpson BM, Pipis SD, Kissen P et al (2004) National Asthma Campaign Manchester Asthma and Allergy Study Group. Early life environmental control, effect on symptoms, sensitization, and lung function at age 3 years. Am J Respir Crit Care Med 170:433–439
Perzanowski MS, Ronmark E, Platts-Mills TA, Lundback B (2002) Effect of cat and dog ownership on sensitization and development of asthma among pre-teenage children. Am J Respir Crit Care Med 166:696–702
Ownby DR, Johnson CC, Peterson EL (2002) Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age. JAMA 288:963–972
Custovic A, Simpson BM, Simpson A, Hallam CL, Marolia H, Walsh D et al (2003) National Asthma Campaign Manchester Asthma and Allergy Study Group. Current mite, cat, and dog allergen exposure, pet ownership, and sensitization to inhalant allergens in adults. J Allergy Clin Immunol 111:402–407
Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J (2003) Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197:403–411
Tulic MK, Holt PG, Sly PD (2002) Modification of acute and late-phase allergic responses to ovalbumin with lipopolysaccharide. Int Arch Allergy Immunol 129:119–128
Portengen L, Preller L, Tielen M, Doekes G, Heederik D (2005) Endotoxin exposure and atopic sensitization in adult pig farmers. J Allergy Clin Immunol 115:797–802
Lau S, Illi S, Platts-Mills TA, Riposo D, Nickel R, Gruber C, Niggemann B et al (2005) Multicentre Allergy Study Group. Longitudinal study on the relationship between cat allergen and endotoxin exposure, sensitization, cat-specific IgG and development of asthma in childhood--report of the German Multicentre Allergy Study (MAS 90). Allergy 60:766–773
Platts-Mills JA, Custis NJ, Woodfolk JA, Platts-Mills TA (2005) Airborne endotoxin in homes with domestic animals, implications for cat-specific tolerance. J Allergy Clin Immunol 116:384–389
Lieutier-Colas F, Meyer P, Pons F, Edelin G, Larsson P, Malmberg P et al (2002) Prevalence of symptoms, sensitization to rats, and airborne exposure to major rat allergen (Rat n 1) and to endotoxin in rat-exposed workers, a cross-sectional study. Clin Exp Allergy 32:1424–1429
Dahlgren MW, Molofsky AB (2018) All along the watchtower: group 2 innate lymphoid cells in allergic responses. Curr Opin Immunol 54:13–19
Crawford G, Hayes MD, Seoane RC et al (2018) Epithelial damage and tissue γδ T cells promote a unique tumor-protective IgE response. Nat Immunol 19:859–870
Jeal H, Draper A, Harris J, Newman Taylor A, Cullinan P, Jones M (2004) Determination of the T cell epitopes of the lipocalin allergen, rat n 1. Clin Exp Allergy 34:1919–1925
Ebner C, Schenk S, Najafian N, Siemann U, Steiner R, Fischer GW et al (1995) Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J Immunol 154:1932–1940
O’Hehir RE, Verhoef A, Panagiotopoulou E, Keswani S, Hayball JD, Thomas WR et al (1993) Analysis of human T cell responses to the group II allergen of Dermatophagoides species, localization of major antigenic sites. J Allergy Clin Immunol 92:105–113
Verhoef A, Higgins JA, Thorpe CJ, Marsh SG, Hayball JD, Lamb JR et al (1993) Clonal analysis of the atopic immune response to the group 2 allergen of Dermatophagoides spp, identification of HLA-DR and -DQ restricted T cell epitopes. Int Immunol 5:1589–1597
Van Neerven RJ, Van de Pol MM, Van Milligen FJ, Jansen HM, Aalberse RC, Kapsenberg ML (1994) Characterisation of cat ander-specific T lymphocytes from atopic patients. J Immunol 152:4203–4210
Carballido JM, Carballido-Perrig N, Kagi MK, Meloen RH, Wuthrich B, Heusser CH et al (1993) T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2. J Immunol 150:3582–3591
Hesselmar B, Aberg B, Eriksson B, Bjorksten B, Aberg N (2003) High-dose exposure to cat is associated with clinical tolerance--a modified Th2 immune response? Clin Exp Allergy 33:1681–1685
Jeal H, Draper A, Harris J, Newman Taylor AJ, Cullinan P, Jones M (2006) Modified TH2 responses at high dose exposures to allergen. Using an occupational model. Am J Respir Crit Care Med 174(1):21–25
Cullinan P, Cook A, Gordon S, Nieuwenhuijsen MJ, Tee RD, Venables KM et al (1999) Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees. Eur Respir J 13:1139–1143
Holt PG (1994) A potential vaccine strategy for asthma and allied atopic diseases during early childhood. Lancet 344:456–458
Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K et al (2003) IL-10 and TGF-Beta cooperate in the regulatory cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33:1205–1214
Jutel M, Akdis M, Blaser K, Akdis CA (2005) Are regulatory T cells the target of venom immunotherapy? Curr Opin Allergy Clin Immunol 116:608–613
Dombrowicz D (2005) Exploiting the innate immune system to control allergic asthma. Eur J Immunol 35:2786–2788
Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M et al (2006) CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med 354:1117–1129
Akbari O, DeKruyff RH, Umetsu DT (2001) Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2:725–731
Hawrylowicz CM (2005) Regulatory T cells and IL-10 in allergic inflammation. J Exp Med 202:1459–1463
Akdis CA, Blaser K (1999) IL-10 induced anergy in peripheral T cell and reactivation by microenvironmental cytokines, two key steps in specific immunotherapy. FASEB J 13:603–609
Ling EM, Robinson DS (2004) Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363:608–615
Bellinghausen I, Konig B, Bottcher I, Knop J, Saloga J (2005) Regulatory activity of human CD4+CD25+ T cells depends on allergen concentration, type of allergen and atopy status of the donor. Immunology 116:103–111
Verhoef A, Alexander C, Kay AB, Larche M (2005) T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity. PLoS Med 2(3):e78
Francis JN, Till SJ, Durham SR (2003) Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 111:1255–1261
Tarzi M, Klunker S, Texier C, Verhoef A, Stapel SO, Akdis CA et al (2006) Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. Clin Exp Allergy 36:465–474
Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K (1998) Role of interleukin 10 in specific immunotherapy. J Clin Invest 102:98–106
Akdis M, Blaser K, Akdis CA (2005) T regulatory cells in allergy, novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 116:961–968
Woodfolk JA (2005) High-dose allergen exposure leads to tolerance. Clin Rev Allergy Immunol 28:43–58
Jones MG, Nielsen J, Welch J, Harris J, Welinder H, Bensryd I et al (2004) Association of HLA-DQ5 and HLA-DR1 with sensitization to organic acid anhydrides. Clin Exp Allergy 34:812–816
Map CE, Balboni A, Baricordi R, Fabbri LM (1997) Human leukocyte antigen associations in occupational asthma induced by isocyanates. Am J Respir Crit Care Med 156:S139–S143
Newman Taylor AJ, Cullinan P, Lympany PA, Harris JM, Dowdeswell RJ, du Bois RM (1999) Interaction of HLA phenotype and exposure intensity in sensitization to complex platinum salts. Am J Respir Crit Care Med 160:435–438
Young RP, Barker RD, Pile KD, Cookson WO, Newman Taylor AJ (1995) The association of HLA-DR3 with specific IgE to inhaled acid anhydrides. Am J Respir Crit Care Med 151:219–221
Jeal H, Draper A, Jones M, Harris J, Welsh K, Newman Taylor A, Cullinan P (2003) HLA associations with occupational sensitisation to rat lipocalin allergens, a model for other animal allergies? J Allergy Clin Immunol 111:759–759
Francis J, Larche M (2005) Peptide-based vaccination, where do we stand? Curr Opin Allergy Clin Immunol 5:537–543
van de Veen W, Stanic B, Wirz OF et al (2016) Role of regulatory B cells in immune tolerance to allergens and beyond. J Allergy Clin Immunol 138:654–665
Gehlhar K, Schlaak M, Becker W, Bufe A (1999) Monitoring allergen immunotherapy of pollen-allergic patients, the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome. Clin Exp Allergy 29:497–506
Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz MA, Blaser K (2003) IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33:1205–1214
Nouri-Aria KT, Wachholz PA, Francis JN, Jabobson MR, Walker SM, Wilcock LK et al (2004) Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 172:3252–3259
Djurup R, Osterballe O (1984) IgG subclass antibody response in grass pollen-allergic patients undergoing specific immunotherapy. Prognostic value of serum IgG subclass antibody levels early in immunotherapy. Allergy 39:433–441
Golden DB, Meyers DA, Kagey-Sobotka A, Valentine MD, Lichtenstein LM (1982) Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy. J Allergy Clin Immunol 69:489–493
Daeron M, Malbec O, Latour S, Arock M, Fridman WH (1995) Regulation of high affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest 95:577–585
Daeron M (1997) Negative regulation of mast cell activation by receptors for IgG. Int Arch Allergy Immunol 113:138–141
Zhu D, Kepley CL, Zhang M, Zhang K, Saxon A (2002) A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon R1-mediated degranulation. Nat Med 8:518–521
Ball T, Sperr WR, Valent P, Lidholm J, Spitzauer S, Ebner C et al (1999) Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy. Eur J Immunol 29:2026–2036
Wachholz PA, Durham SR (2003) Induction of ‘blocking’ IgG antibodies during immunotherapy. Clin Exp Allergy 33:1171–1174
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Jones, M.G. (2019). Understanding of the Molecular Mechanisms of Allergy. In: Lympany, P., Jones, M. (eds) Allergy. Methods in Molecular Biology, vol 2020. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9591-2_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9591-2_1
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9589-9
Online ISBN: 978-1-4939-9591-2
eBook Packages: Springer Protocols